Center for Pediatric Inflammatory Bowel Disease

drhyams.pngUnder the direction of Jeffrey S. Hyams, MD, an international pioneer and leader of advanced inflammatory bowel disease treatments, the Center for Pediatric Inflammatory Bowel Disease (IBD) at Connecticut Children's is the largest between Boston and New York.

Our team provides patient- and family-centered care to more than 600 children affected by ulcerative colitis and Crohn’s disease. Care at Connecticut Children’s includes access to the very latest clinical therapies including novel biologic agents being evaluated in clinical trials.

As a leader in IBD research, our top physicians and researchers lead a range of clinical trials and are at the forefront of scientific discoveries improving the quality of life for children living with Crohn's disease and ulcerative colitis. Research interests include:

  • International clinical trials for Crohn's disease and ulcerative colitis
  • Translational studies to better understand response to standard of care therapies
  • IBD and its effect on bone density
  • Mucosal immunology and allergy
  • Interactions between microorganisms and epithelial surfaces
  • Natural history of IBD
  • Nutrition support

Juvenile IBD Support Group

Facilitated by Therese Loughran, MSW, the IBD support group for Connecticut Children’s patients with Crohn's disease and ulcerative colitis meets on the first Thursday of each month, from September through May. For more information, contact Petra Amrein, 860.545.8056.